Axogen, Inc.·4

May 8, 4:06 PM ET

Quackenbush Doris 4

4 · Axogen, Inc. · Filed May 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Axogen (AXGN) Sales VP Doris Quackenbush Sells Shares

What Happened

  • Doris Quackenbush, Sales Vice President of Axogen, sold 3,878 shares of Axogen stock in an open-market disposition on May 7, 2026.
  • The reported weighted-average sale price was $43.51 per share, for aggregate proceeds of approximately $168,720. The filing notes the shares were sold in multiple transactions at prices ranging from $43.50 to $44.00.

Key Details

  • Transaction date: 2026-05-07; Report filed: 2026-05-08 (appears timely).
  • Price: Weighted average $43.51; range $43.50–$44.00 per footnote.
  • Shares disposed: 3,878; Proceeds: ~$168,720.
  • Shares owned after the transaction: Not specified in the supplied filing excerpt.
  • Footnote: F1 clarifies the reported price is a weighted average and the seller can provide a breakdown of shares sold at each price upon request.
  • Transaction code: S (sale/open-market or private sale).

Context

  • This was a sale (disposition). Sales by insiders are frequently routine and can reflect personal liquidity needs or portfolio management; they are generally less informative about company prospects than insider purchases.
  • No option exercise, gift, or award was reported in this transaction.

Insider Transaction Report

Form 4
Period: 2026-05-07
Transactions
  • Sale

    Common Stock

    [F1]
    2026-05-07$43.51/sh3,878$168,72092,416 total
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.50 to $44.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Signature
/s/ Marc Began, as attorney-in-fact for Doris Quackenbush|2026-05-08

Documents

1 file
  • 4
    wk-form4_1778270784.xmlPrimary

    FORM 4